Since we wrote our article on the 18th February about the performance of Novacyt shares on the back of their successful Coronavirus test, the share price has fallen dramatically.

I thought Stuart made a great point about this stock being a hedge against the virus, particularly in light of its performance as the big headlines spooked the financial markets. News of Covid-19 has left the front pages of late and the markets have regained the ground they lost.

Will Novacyt prove a successful hedge against the spread of the #Coronavirus? #NCYThttps://t.co/aHUW2sAZJu

— The Armchair Trader (@armchairtweets) February 24, 2020

We don’t know yet if the Coronavirus will escalate, or disappear as we head in to spring. So I’m keeping a few shares for now, as a hedge against the worst case scenario. I’d rather lose money than see things escalate, but the investment is there just in case.

https://www.thearmchairtrader.com/novacyt-shares-soar-on-back-of-coronavirus-test/